fda bpc-157 warning compounding What's behind the push to make peptide therapies more readily available : NPR FDA takes coser look at
Description
Felt better

Avis NE et al

Clear language, careful claims, no dosing instructions

5-amino-1mq offers a different profile
You people seriously are considering a 2nd dose after these kind of adverse effects from the 1st

not assumed
